Owens, C., Tritz, Z., Ayasoufi, K., Wolf, D., Parney, I., Hanson, M., … Maynes, M. (2023). EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH.-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS. In NEURO-ONCOLOGY (Vol. 25).

Owens, Carley, Zachariah Tritz, Katayoun Ayasoufi, Delaney Wolf, Ian Parney, Michael Hanson, Jin Fang, et al. “EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH.-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS.” In NEURO-ONCOLOGY, Vol. 25, 2023.

Owens C, Tritz Z, Ayasoufi K, Wolf D, Parney I, Hanson M, et al. EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH.-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS. In: NEURO-ONCOLOGY. 2023.

Owens, Carley, et al. “EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH.-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS.” NEURO-ONCOLOGY, vol. 25, 2023.

Owens C, Tritz Z, Ayasoufi K, Wolf D, Parney I, Hanson M, Fang J, Johnson A, Campian J, Fain C, Himes B, Malo C, Goddery E, Yokanovich L, Wang C, Vile R, Moynihan K, Irvine DJ, Mercano R, Wittrup D, Maynes M. EXTENDED HALF-LIFE IL-2 SYNERGIZES WITH.-PD-1 FOR TREATMENT OF PRECLINICAL MURINE GLIOBLASTOMA MODELS. NEURO-ONCOLOGY. 2023.